To beta block or not to beta block; that is the question

Critical Care

Volumn 19, Issue 1, 2015, Pages

  Ince, Can ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ESMOLOL; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LEVOSIMENDAN; MILRINONE; TUMOR NECROSIS FACTOR ALPHA; PROPANOLAMINE DERIVATIVE;

CRITICALLY ILL PATIENT; HEART HEMODYNAMICS; HEART RATE; HEART STROKE VOLUME; HUMAN; INTESTINE BLOOD FLOW; LUNG ARTERY PRESSURE; MESENTERY BLOOD FLOW; MICROCIRCULATION; NONHUMAN; NOTE; PIG; PRIORITY JOURNAL; PROGNOSIS; SEPSIS; SUBLINGUAL GLAND; SURVIVAL; TACHYCARDIA; ANIMAL; DISEASE MODEL; DRUG EFFECTS; FEMALE; GASTROINTESTINAL TRACT; SHOCK, SEPTIC;

ANIMALS; DISEASE MODELS, ANIMAL; FEMALE; GASTROINTESTINAL TRACT; MICROCIRCULATION; PROPANOLAMINES; SHOCK, SEPTIC; SUBLINGUAL GLAND;

EID: 84956774315     PISSN: 13648535     EISSN: 1466609X     Source Type: Journal    
DOI: 10.1186/s13054-015-1059-6     Document Type: Note

References (12)

1. Jacquet-Lagrèze M, Allaouchiche B, Restagno D, Paquet C, Ayoub JY, Etienne J, et al. Gut and sublingual microvascular effect of esmolol during septic shock in a porcine model. Crit Care. 2015;4:19-241.
2. Morelli A, Ertmer C, Westphal M, Rehberg S, Kampmeier T, Ligges S, et al. Effect of heart rate control with esmolol on hemodynamic and clinical outcomes in patients with septic shock: a randomized clinical trial. JAMA. 2013;310:1683-91.
3. de Montmollin E, Aboab J, Arnaud Mansart A, Annane D. Bench-to-bedside review: beta-adrenergic modulation in sepsis. Crit Care. 2009;13:230.
4. Morelli A, Donati A, Ertmer C, Rehberg S, Kampmeier T, Orecchioni A, et al. Microvascular effects of heart rate control with esmolol in patients with septic shock: a pilot study. Crit Care Med. 2013;41:2162-8.
5. Aboab J, Sebille V, Jourdain M, Mangalaboyi J, Gharbi M, Mansart A, et al. Effects of esmolol on systemic and pulmonary hemodynamics and on oxygenation in pigs with hypodynamic endotoxin shock. Inten Care Med. 2011;37:1344-51.
6. Vellinga NA, Boerma EC, Koopmans M, Donati A, Dubin A, Shapiro NI, et al. International study on microcirculatory shock occurrence in acutely ill patients. Crit Care Med. 2015;43:48-56.
7. De Backer D, Donadello K, Sakr Y, Ospina-Tascon G, Salgado D, Scolletta S, et al. Microcirculatory alterations in patients with severe sepsis: impact of time of assessment and relationship with outcome. Crit Care Med. 2013;41:791-9.
8. Edul VS, Enrico C, Laviolle B, Vazquez AR, Ince C, Dubin A. Quantitative assessment of the microcirculation in healthy volunteers and in patients with septic shock. Crit Care Med. 2012;40:1443-8.
9. Fries M, Ince C, Rossaint R, Bleilevens C, Bickenbach J, Rex S, et al. Levosimendan but not norepinephrine improves microvascular oxygenation during experimental septic shock. Crit Care Med. 2008;36:1886-91.
10. Morelli A, Donati A, Ertmer C, Rehberg S, Lange M, Orecchioni A, et al. Levosimendan for resuscitating the microcirculation in patients with septic shock: a randomized controlled study. Crit Care. 2010;14:R232.
11. Kimmoun A, Louis H, Kattani NA, Delemazure J, Dessales N, Wei C, et al. β1-Adrenergic inhibition improves cardiac and vascular function in experimental septic shock. Crit Care Med. 2015;43:e332-40.
12. Mori K, Morisaki H, Yajima S, Suzuki T, Ishikawa A, Nakamura N, et al. Beta-1 blocker improves survival of septic rats through preservation of gut barrier function. Intens Care Med. 2011;37:1849-56.